HEXABODY
LIVE

Serial Number

79154175

Owner

Genmab B.V.

Attorney

Max Vern

Filing Date

Apr 14, 2014

Add to watchlist:

No watchlists yet
View on USPTO

HEXABODY Trademark

Serial Number: 79154175 • Registration: 4857201

HEXABODY is a trademark filed by Genmab B.V. on April 14, 2014. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

Genmab B.V. (4 trademarks)

Uppsalalaan 15

Entity Type: 16

Trademark Details

Filing Date

April 14, 2014

Registration Date

November 24, 2015

Published for Opposition

September 8, 2015

Cancellation Date

April 14, 2024

Goods & Services

[ Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations based on antibodies, bi- and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to the treatment of cancer, infectious, immune, autoimmune, inflammatory, neurodegenerative and cardiovascular diseases ]

[ Chemical, biochemical, biological, and biotechnological, preparations, namely, antibodies, bi- and multispecific antibodies as well as fragments, monovalent antibodies, derivatives of conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases ]

[ Legal services in the form of patent exploitation, namely, patent consultation, patent licensing, and providing information about patent rights; licensing of intellectual property in the field of medicine ]

Medical, scientific and biological research; medical, scientific and biological research in the field of antibodies, bi- and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies, bi- and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; [ computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy; ] development of pharmaceuticals containing antibodies, bi- and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 8, 2024 DENA
DEATH OF INTERNATIONAL REGISTRATION
Nov 8, 2024 DETH
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 5, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 5, 2024 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Jun 5, 2024 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 5, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 5, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 5, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 5, 2024 COAR
PARTIAL INVALIDATION PROCESSED BY THE IB
Oct 9, 2023 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 6, 2023 INPS
INVALIDATION PROCESSED
Sep 6, 2023 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 3, 2023 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Dec 3, 2022 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Dec 3, 2022 71.P
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Nov 23, 2022 EROP
POST REGISTRATION ACTION MAILED - SEC.71
May 25, 2022 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 24, 2022 APRE
TEAS SECTION 71 RECEIVED
Nov 23, 2021 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 24, 2020 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 14, 2018 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Nov 10, 2017 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Apr 20, 2017 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 9, 2017 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 11, 2016 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Feb 24, 2016 FICS
FINAL DISPOSITION PROCESSED
Feb 24, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 24, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 24, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 8, 2015 NPUB
PUBLISHED FOR OPPOSITION
Sep 8, 2015 PUBO
NOTIFICATION PROCESSED BY IB
Sep 4, 2015 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 19, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 19, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 19, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 6, 2015 PREV
ASSIGNED TO LIE
Aug 3, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 22, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 22, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 22, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 22, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 22, 2015 CNEA
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Jul 20, 2015 CREV
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 3, 2015 CRCV
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 3, 2015 GNFN
FINAL REFUSAL E-MAILED
Jun 3, 2015 GNFR
FINAL REFUSAL WRITTEN
Jun 3, 2015 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 12, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 12, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 12, 2015 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 12, 2015 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 12, 2015 REAP
REFUSAL PROCESSED BY IB
Nov 28, 2014 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 13, 2014 RFCS
REFUSAL PROCESSED BY MPU
Nov 13, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 12, 2014 RFCR
NON-FINAL ACTION WRITTEN
Nov 11, 2014 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 11, 2014 MAFR
ASSIGNED TO EXAMINER
Nov 7, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 7, 2014 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 31, 2014 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 30, 2014 REPR